Skip to main content
Equibles

BOOTHBAY FUND MANAGEMENT, LLC

Position in LPCN — Lipocine Inc.

CIK 1549230 NEW YORK, NY
Back to LPCN Full portfolio

Position in LPCN

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$359,646
-$762,845 QoQ
Shares Held
140,487
0.0% QoQ
Ownership
1.70%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#6
of 36 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in LPCN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BOOTHBAY FUND MANAGEMENT, LLC holds $666,641,771 across 159 Biotechnology names. LPCN ranks #120 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RVMD
Revolution Medicines, Inc.
 465,787 $87,232,589
2 ABVX
Abivax S.A.
 563,367 $75,074,286
3 EXEL
Exelixis, Inc.
 804,095 $43,750,808
4 PCVX
Vaxcyte, Inc.
 534,163 $31,050,895
5 COGT
Cogent Biosciences, Inc.
 692,825 $26,812,327
6 CGEM
Cullinan Therapeutics, Inc.
 1,082,611 $19,714,346
7 TNGX
Tango Therapeutics, Inc.
 500,497 $15,645,536
8 AVTX
Avalo Therapeutics, Inc.
 702,051 $12,973,902

All Filings in LPCN

Export CSV
3 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $359,646 140,487
2026-03-31 $1,122,491 140,487
2025-12-31 $440,790 54,893